Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.67 |
| ▸ | CHRM2 | P08172 | 3/20 | 0.62 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.62 |
| ▸ | CHRM3 | P20309 | 3/20 | 0.62 |
| ▸ | IDO1 | P14902 | 2/20 | 0.61 |
| ▸ | AGXT | P21549 | 2/20 | 0.61 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.59 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.59 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.56 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.55 |
| ▸ | HTR1A | P08908 | 1/20 | 0.55 |
| ▸ | DRD2 | P14416 | 1/20 | 0.55 |
| ▸ | MAOB | P27338 | 1/20 | 0.53 |
| ▸ | CMA1 | P23946 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3689085 | 0.89 | CHRM2 (0.63) | TAAR1CHRM2CHRM1CHRM3IDO1 | |
| SCHEMBL30080050 | 0.87 | TAAR1 (0.77) | TAAR1CHRM2CHRM1CHRM3IDO1 | |
| SCHEMBL723511 | 0.87 | TAAR1 (0.77) | TAAR1CHRM2CHRM1CHRM3IDO1 | |
| SCHEMBL863899 | 0.85 | CHRM2 (0.59) | TAAR1CHRM2CHRM1CHRM3IDO1 | |
| SCHEMBL4142939 | 0.85 | CHRM2 (0.59) | TAAR1CHRM2CHRM1CHRM3IDO1 | |
| SCHEMBL29986862 | 0.83 | TAAR1 (0.71) | TAAR1CHRM2CHRM1CHRM3IDO1 | |
| SCHEMBL21002016 | 0.83 | TAAR1 (0.71) | TAAR1CHRM2CHRM1CHRM3IDO1 | |
| SCHEMBL21002162 | 0.83 | TAAR1 (0.71) | TAAR1CHRM2CHRM1CHRM3IDO1 | |
| SCHEMBL96112 | 0.83 | TAAR1 (0.60) | TAAR1CHRM2CHRM1CHRM3IDO1 | |
| SCHEMBL21002124 | 0.82 | TAAR1 (0.69) | TAAR1CHRM2CHRM1CHRM3IDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 89 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2007069986-A1 | NEW OXABISPIDINE COMPOUNDS FOR THE TREATMENT OF CARDIAC ARRHYTHMIAS | ASTRAZENECA AB (SE) | 2007-06-21 | — | — | WO | claimed |
| CN-1192021-C | 3-azabicyclo [3.1.0] hexane derivatives as opioid receptor ligands | PFIZER LTD (US) | 2005-03-09 | — | — | CN | claimed |
| CN-1331679-A | 3-azabicyclo [3.1.0] hexane derivatives as opiate receptors ligands | PFIZER LTD (US) | 2002-01-16 | — | — | CN | claimed |
| US-9955689-B2 | Method for promoting plant growth | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2018-05-01 | — | — | US | disclosed |
| US-9894901-B2 | Method for promoting plant growth | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2018-02-20 | — | — | US | disclosed |
| US-9872493-B2 | Method for promoting plant growth | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2018-01-23 | — | — | US | disclosed |
| US-20150305332-A1 | METHOD FOR PROMOTING PLANT GROWTH | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2015-10-29 | — | — | US | disclosed |
| US-20150289512-A1 | METHOD FOR PROMOTING PLANT GROWTH | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2015-10-15 | — | — | US | disclosed |
| US-20150289506-A1 | METHOD FOR PROMOTING PLANT GROWTH | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2015-10-15 | — | — | US | disclosed |
| US-20150282482-A1 | METHOD FOR PROMOTING PLANT GROWTH | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2015-10-08 | — | — | US | disclosed |
| EP-2926660-A1 | METHOD FOR PROMOTING PLANT GROWTH | Sumitomo Chemical Company Limited (JP) | 2015-10-07 | — | — | EP | disclosed |
| CN-1039415-A | New 1, the preparation method of 3-3-disubstituted piperidine derivatives | PFIZER (GB) | 1990-02-07 | — | — | CN | disclosed |
| CN-1033995-A | 4 (5)-imidazoles that suppress aromatase enzyme | FARMOS OY (FI) | 1989-07-19 | — | — | CN | disclosed |
| EP-0105243-B1 | SEPARATION OF RACEMIC 1-PROPYL-3-ARYL PIPERIDINES | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1988-08-03 | — | — | EP | disclosed |
| EP-0105243-A2 | Separation of racemic 1-propyl-3-aryl piperidines | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1984-04-11 | — | — | EP | disclosed |
| US-4195178-A | Methylenecyclopentane derivatives | THE UPJOHN COMPANY (US) | 1980-03-25 | — | — | US | disclosed |
| US-4181798-A | Methylenecyclopentane derivatives | THE UPJOHN COMPANY (US) | 1980-01-01 | — | — | US | disclosed |
| US-4175202-A | 4,5,6-Trinor-3,7,-inter-m-phenylene prostaglandin A1 analogs | THE UPJOHN COMPANY (US) | 1979-11-20 | — | — | US | disclosed |
| US-4100192-A | Inter-phenylene-PG amides | THE UPJOHN COMPANY (US) | 1978-07-11 | — | — | US | disclosed |
| US-4084058-A | HYPOTENSIVES, ANTICOAGULANTS | THE UPJOHN COMPANY (US) | 1978-04-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150289506-A1 | METHOD FOR PROMOTING PLANT GROWTH | FGF2, BROX, BOLA2; BOLA2B | TAAR1 833/4885CHRM2 4198/4885CHRM1 4445/4885 |
| US-20150305332-A1 | METHOD FOR PROMOTING PLANT GROWTH | FGF1, BROX, FGF2 | TAAR1 305/4885CHRM2 2825/4885CHRM1 2104/4885 |
| US-20150282482-A1 | METHOD FOR PROMOTING PLANT GROWTH | BOLA2; BOLA2B, BROX, TET1 | TAAR1 1423/4885CHRM2 3115/4885CHRM1 3336/4885 |
| US-20150289512-A1 | METHOD FOR PROMOTING PLANT GROWTH | FGF1, MKI67, FGF2 | TAAR1 2317/4885CHRM2 3391/4885CHRM1 2538/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.